The PHARAO study: prevention of hypertension with the angiotensin-converting enzyme inhibitor ramipril in patients with high-normal blood pressure – a prospective, randomized, controlled prevention trial of the German Hypertension League

Lüders, Stephan; Schrader, Joachim; Berger, Jürgen; Unger, Thomas; Zidek, Walter; Böhm, Michael; Middeke, Martin; Motz, W.; Lübcke, Cornelia; Gansz, Andrea; Brokamp, Ludmer; E. Schmieder, Roland; Trenkwalder, Peter; Haller, Herrmann; Dominiak, Peter

doi:10.1097/hjh.0b013e3282ff8864

Public

The PHARAO study: prevention of hypertension with the angiotensin-converting enzyme inhibitor ramipril in patients with high-normal blood pressure – a prospective, randomized, controlled prevention trial of the German Hypertension League

Published in Journal of Hypertension • Jul 1, 2008

Authors:

Stephan Lüders

Joachim Schrader

Jürgen Berger

Abstract

BACKGROUND: The prevention of hypertension with the angiotensin-converting enzyme inhibitor ramipril in patients with high-normal blood pressure study addresses the issue of whether progression to manifest hypertension in patients with high-normal blood pressure can be prevented with treatment. METH...

Subject

Medicine

Ramipril

Blood pressure

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!